Tech Company Financing Transactions
PFx Biotech Funding Round
PFx Biotech, based in Porto, secured $2.9 million from Beta Fund, EIT Food and European Innovation Council Fund.
Transaction Overview
Company Name
Announced On
6/6/2025
Transaction Type
Venture Equity
Amount
$2,900,000
Round
Seed
Proceeds Purpose
This investment reflects our conviction in biology-driven solutions to reshape the food system and our confidence in the PFx team to lead that change.
Company Information
Company Status
Private & Independent
Industry
AgTech
Mailing Address
Rua Alfredo Allen 455
Porto, 4200-374
Portugal
Porto, 4200-374
Portugal
Phone
Undisclosed
Website
Email Address
Overview
PFx Biotech is a cutting-edge biotech Portuguese company, founded in 2022 and based in UPTEC, Porto, that harnesses the power of biology to create healthier lives and a better planet. Human milk proteins are the golden nutritional and health-promoting proteins in early life nutrition. By producing highly bioactive alternative human milk proteins, through precision fermentation, PFx is creating a new category of ingredients that will support and boost the immune system. Beyond new generation infant formula, our non-allergenic, GMO-, dairy- and animal-free proteins are easily digestible and bioavailable, making them a perfect choice for all populations, including those with specific nutritional needs, namely elderly and athletes.
Management Team
Browse more venture capital transactions:
Prev: 6/6/2025: Anysphere venture capital transaction
Next: 6/6/2025: Lendurai venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs